Pacific Therapeutics Ltd. Selected to Present at LARTA Venture Forum

Doug Unwin President & CEO is pleased to announce that Pacific Therapeutics was chosen by The Consulate General of Canada in Los Angeles and LARTA Institute to participate in a unique 3-phase mentorship, showcase and partnering program and be a presenter at the 2008 Life Sciences Venture Forum in Santa Clara, California, on May 30, 2008, the nation's largest and longest running showcase of quality emerging companies.

About the Life Sciences Venture Forum
Larta Institute's Venture Forum is the country's largest - and longest running - showcase of innovation and entrepreneurship (started in 1995). In the last 4 years alone 39 life science presenting companies have raised over $68 million in funding, 558 CDA's have been signed, and 302 negotiations with investors and partners have taken place.

About Pacific Therapeutics
Pacific Therapeutics Ltd. (PTL) is a Development stage Specialty Pharmaceutical Company, poised to begin Clinical Trials. The company is focused on developing late stage clinical therapies and in licensed novel compounds for pulmonary fibrosis indications. PTL's lead compound PTL-202 is a combination of already approved drugs with a well established safety profile. The company will take this therapy into a Clinical trial in Pulmonary Fibrosis. PTL will retain the marketing rights to its compounds and build its own sales and marketing expertise to access the concentrated, niche Pulmonary Fibrosis markets. Together these markets represent an opportunity in excess of $1.5 billion.

Contact:

Doug Unwin
President & CEO
Pacific Therapeutics Ltd.
Phone: (604) 738-1049
Email: unwin@pacifictherapeutics.com